[Asia Economy Reporter Hyunseok Yoo] AI vision specialist company Raonpeople announced on the 6th that it has signed a strategic business agreement with Yonsei University Industry-Academic Cooperation Foundation for the development of AI convergence medical technology, including the 'technology transfer for sleep apnea diagnosis.'


Raonpeople obtained an exclusive license for two patents, including the 'sleep apnea diagnosis method using machine learning,' filed domestically and in the United States by Yonsei University Industry-Academic Cooperation Foundation, and is developing the sleep apnea AI diagnostic device 'Laon Sleep.' The plan is to commercialize it after receiving approval from the Ministry of Food and Drug Safety through cooperation with Yonsei Medical Center and clinical trials.


Laon Sleep is a sleep apnea AI diagnostic solution developed with the participation of medical staff and engineering researchers from Yonsei University, combined with Raonpeople's AI solution. It quickly interprets whether a patient requires surgery or prescription of devices such as CPAP by using only CBCT (dental CT imaging equipment) data, AI solutions, and related biometric information, as well as assessing the severity and criticality of sleep apnea. For mild patients, devices such as mouthpieces (intraoral devices to improve snoring) are produced with 3D printers and prescribed, improving diagnostic accuracy and drastically reducing consultation time, which is expected to increase satisfaction for both hospitals and patients.


Lee Seok-jung, CEO of Raonpeople, stated, "Sleep apnea is recognized as a serious disease on its own and stimulates the cardiovascular system, increasing blood pressure and heart rate, leading to various complications such as hypertension, heart disease, stroke, malocclusion, depression, fatigue, and growth retardation." He added, "Through Laon Sleep, we expect to satisfy patients' sleep needs and improve overall quality of life, and we plan to secure the global market based on U.S. patents in the future."



The agreement ceremony held at Kim Soon-jeon Hall, Baekyangnuri, Yonsei University, was attended by Raonpeople CEO Lee Seok-jung, Vice President Kim Ju-young, Yonsei University Industry-Academic Cooperation Foundation Director Lee Chung-yong, Director of Medical Science Research Institute Choi Jae-young, Dean of the College of Engineering Myung Jae-min, and Dean of the College of Dentistry Kim Ui-sung. On this day, Raonpeople and Yonsei University agreed to lead the global AI medical market and create new medical value by expanding solutions into various fields such as remote medical care, rehabilitation robots, and in vitro diagnostic systems through the convergence of AI technology and next-generation medical technology, as well as developing AI medical devices.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing